KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $387,727 | -39.5% | 57,356 | +29.9% | 0.02% | -26.7% |
| Q3 2022 | $641,000 | -18.1% | 44,166 | -44.4% | 0.03% | -6.2% |
| Q2 2022 | $783,000 | -12.1% | 79,499 | +31.6% | 0.03% | -3.0% |
| Q1 2022 | $891,000 | +42.1% | 60,399 | +27.4% | 0.03% | +50.0% |
| Q4 2021 | $627,000 | +2.6% | 47,399 | +35.4% | 0.02% | -15.4% |
| Q3 2021 | $611,000 | -43.3% | 34,999 | -22.2% | 0.03% | -40.9% |
| Q2 2021 | $1,078,000 | -54.8% | 44,999 | -51.5% | 0.04% | -55.1% |
| Q1 2021 | $2,387,000 | +790.7% | 92,863 | +557.3% | 0.10% | +880.0% |
| Q4 2020 | $268,000 | – | 14,129 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |